InVivo Therapeutics Holdings Corp. (NVIV) financial statements (2022 and earlier)

Company profile

Business Address ONE KENDALL SQUARE
CAMBRIDGE, MA 02139
State of Incorp. NV
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments19,03119,4936,60216,66012,91033,04120,194
Cash and cash equivalents19,03119,4936,60216,66012,91021,46420,194
Short-term investments     11,577 
Restricted cash and investments  44361361361
Prepaid expense   17   
Other undisclosed current assets111163177444535451184
Total current assets:19,14219,6566,78317,12513,80633,85320,739
Noncurrent Assets
Operating lease, right-of-use asset1,2299281,211
Property, plant and equipment1278573100157510938
Prepaid expense1,1221,1221,122    
Restricted cash and investments150110110110   
Other noncurrent assets 9261,04282421115
Total noncurrent assets:2,6282,2542,5421,2522399311,053
TOTAL ASSETS:21,77021,9109,32518,37714,04534,78421,792
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,2511,6452,3692,1052,6262,970895
Accounts payable6054819428159881,011521
Accrued liabilities1,6461,1641,4271,2901,6381,959374
Debt  294100452423395
Derivative instruments and hedges, liabilities    41,3141,907
Deferred revenue and credits30141115
Other undisclosed current liabilities361327     
Total current liabilities:2,6121,9722,6632,2053,1124,8483,312
Noncurrent Liabilities
Long-term debt and lease obligation9496931,020 4008521,275
Long-term debt, excluding current maturities    4008521,275
Operating lease, liability9496931,020
Liabilities, other than long-term debt94595961423135276
Deferred revenue and credits367135276
Other liabilities9459596156  
Total noncurrent liabilities:1,0437521,079618239871,551
Total liabilities:3,6552,7243,7422,2663,9355,8354,863
Stockholders' equity
Stockholders' equity attributable to parent18,11519,1865,58316,11110,11028,94916,929
Common stock3321111
Additional paid in capital256,241247,417224,741223,440194,016185,955150,497
Accumulated deficit(238,129)(228,234)(219,160)(207,330)(183,907)(157,007)(133,569)
Total stockholders' equity:18,11519,1865,58316,11110,11028,94916,929
TOTAL LIABILITIES AND EQUITY:21,77021,9109,32518,37714,04534,78421,792

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Operating expenses(9,900)(9,097)(11,497)(12,767)(24,593)(24,063)(22,398)
Operating loss:(9,900)(9,097)(11,497)(12,767)(24,593)(24,063)(22,398)
Nonoperating income (expense)523(333)(10,656)(2,152)625(10,916)
Investment income, nonoperating   (12,165)   
Other nonoperating income (expense)24(587)1,303(2,152)625(10,916)
Interest and debt expense    (74)(155)(126)
Loss before gain (loss) on sale of properties:(9,895)(9,074)(11,830)(23,423)(26,819)(23,593)(33,440)
Other undisclosed net income    74  
Net loss:(9,895)(9,074)(11,830)(23,423)(26,745)(23,593)(33,440)
Other undisclosed net income attributable to parent      126
Net loss attributable to parent:(9,895)(9,074)(11,830)(23,423)(26,745)(23,593)(33,314)
Other undisclosed net income available to common stockholders, basic     155 
Net loss available to common stockholders, diluted:(9,895)(9,074)(11,830)(23,423)(26,745)(23,438)(33,314)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(9,895)(9,074)(11,830)(23,423)(26,745)(23,593)(33,440)
Comprehensive loss, net of tax, attributable to parent:(9,895)(9,074)(11,830)(23,423)(26,745)(23,593)(33,440)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: